+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Brain Ischemia Drug"

From
From
Glial Cell Line Derived Neurotrophic Factor - Pipeline Review, H2 2020 - Product Thumbnail Image

Glial Cell Line Derived Neurotrophic Factor - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 59 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Brain Ischemia is a type of cardiovascular drug used to treat a lack of blood flow to the brain. It is used to treat stroke, transient ischemic attack (TIA), and other conditions caused by a lack of oxygen to the brain. Brain Ischemia drugs work by increasing blood flow to the brain, reducing the risk of stroke and other complications. These drugs can also be used to reduce the risk of recurrent stroke and improve the quality of life for those affected. Commonly used Brain Ischemia drugs include aspirin, clopidogrel, and warfarin. Brain Ischemia drugs are widely available and are used in many countries around the world. They are typically prescribed by a doctor and are available in both generic and brand-name forms. Companies that produce Brain Ischemia drugs include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Bristol-Myers Squibb. Show Less Read more